| 双歧杆菌DM-8504活菌制剂预防化疗引起的腹泻疗效观察 |
| |
| 引用本文： | 刘基巍,周涛,张洁,陈亚敏,蔡欣.双歧杆菌DM-8504活菌制剂预防化疗引起的腹泻疗效观察[J].中国微生态学杂志,2000,12(3):178-179. |
| |
| 作者姓名： | 刘基巍 周涛 张洁 陈亚敏 蔡欣 |
| |
| 作者单位： | 大连医科大学第一临床学院,肿瘤科,辽宁,大连,116011 |
| |
| 基金项目： | 省教委科题!双歧杆菌 DM— 85 0 4抗肿瘤临床作用 |
| |
| 摘 要： | ２２例肿瘤化疗患者采用随机对照交叉试验，对照组采用单纯化疗实验组采用化疗＋双歧杆菌活菌制剂。结果显示双歧杆菌活菌制剂可预防化疗引起的腹泻（对照组腹泻率４５．５％，实验组为２７．３％），并可改善腹珠反应程度（重度腹泻率对照组为１８．２％，初级组为４．５％），有统计学差异（Ｐ〈０．０１），提示双歧杆菌活菌制剂预防化疗引起的腹泻疗效确切。
|
| 关 键 词： | 双歧杆菌 腹泻 DM－8504活菌制剂 预防 |
| 修稿时间： | 2000-04-15 |
PROPHALYXIS OF CHEMOTHERAPY-INDUCED DIARREA BY BIFIDOBACTERIUM AGENT |
| |
| LIU Ji wei,ZHOU Tao,ZHANG Jie,et al..PROPHALYXIS OF CHEMOTHERAPY-INDUCED DIARREA BY BIFIDOBACTERIUM AGENT[J].Chinese Journal of Microecology,2000,12(3):178-179. |
| |
| Authors: | LIU Ji wei ZHOU Tao ZHANG Jie |
| |
| Abstract: | cancer patients were auto-across-contrl randomised into test group (chemotherapy Bifidobacterium agent), and control group (chemotherapy only). Prophalyxis of chemotherapy-induced diarrea by Bifidobacterium agent was effctive (diarrea 45.5% in control group, 27.3% in test group), and reduced grades of diarrea (heavy diarrea 18.2% in control group, 4.5 in test group), significantly different(P<0.01), indicating that Prophalyxis of chemotherapy-induced diarrea by Bifidobacterium agent was confirmed. |
| |
| Keywords: | bifidobacterium chemotherapy diarrea |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
